Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Janssen Pharmaceutica Nv
Janssen Pharmaceutica Nv A Corporation
Janssen Pharmaceutica Nv_20131212
Janssen Pharmaceutica Nv_20100107
  

Janssen Pharmaceutica Nv patents

Recent patent applications related to Janssen Pharmaceutica Nv. Janssen Pharmaceutica Nv is listed as an Agent/Assignee. Note: Janssen Pharmaceutica Nv may have other listings under different names/spellings. We're not affiliated with Janssen Pharmaceutica Nv, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "J" | Janssen Pharmaceutica Nv-related inventors




Date Janssen Pharmaceutica Nv patents (updated weekly) - BOOKMARK this page
11/16/17 new patent  Trifluoromethyl alcohols as modulators of roryt
11/16/17 new patent  Flap modulators
11/09/17Hiv replication inhibiting pyrimidines
11/09/174-aminoquinazolin compounds as prolyl hydroxylase inhibitors
11/09/17Macrocyclic quinazole derivatives and their use as mtki
11/09/17Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
11/02/176-aminopyridin-3-yl thiazoles as modulators of roryt
10/26/174-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/19/17Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor
10/19/17Antibodies to paliperidone haptens and use thereof
10/19/17Antibodies to risperidone and use thereof
10/12/17Gpr40 agonists in anti-diabetic drug combinations
10/12/17Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancer
10/12/17Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes
10/05/17Inhibitors of bruton's tyrosine kinase and their use
10/05/17Inhibitors of bruton's tyrosine kinase and their use
09/28/176,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
09/21/176,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
09/21/17A deuterated triazolopyridazine as a kinase modulator
09/14/17Alkyl linked quinolinyl modulators of rorγt
09/14/17Methods of treating depression using orexin-2 receptor antagonists
09/07/17Compositions containing ibrutinib
08/24/17Antibodies to olanzapine haptens and use thereof
08/17/17Substituted thiohydantoin derivatives as androgen receptor antagonists
08/17/17Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
08/10/17Substituted 1,2,3-triazoles as nr2b-selective nmda modulators
08/03/17Sensor device and carriers
08/03/176,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
08/03/176,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
08/03/17Detection of circulating jc polyomavirus (jcpyv) micrornas as biomarker for jcpyv infection
07/20/17Substituted 2-azabicycles and their use as orexin receptor modulators
07/20/17Antibodies to aripiprazole haptens and use thereof
07/13/17R2r1/2 in diagnosis and therapy
07/06/17N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
06/29/17Quinolinyl modulators of roryt
06/22/17Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1h-imidazo[1,2-b]pyrazole derivatives as ros1 inhibitors
06/22/17P2x7 modulators
06/22/17Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4h-pyrazolo[1,5-a][1,4]diazepine derivatives as ros1 inhibitors
06/22/17Antibodies to risperidone and use thereof
06/22/17Antibodies to quetiapine and use thereof
06/15/17Milk filtration devices and methods for filtering
06/08/17Quinazolinone derivatives as parp inhibitors
06/08/17Substituted pyridine derivatives useful as c-fms kinase inhibitors
05/11/17Dosing regimen associated with long acting injectable paliperidone esters
05/11/17Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
05/11/17Antibodies to paliperidone haptens and use thereof
05/04/17Hiv replication inhibiting pyrimidines
05/04/17Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the same
05/04/17Anti-il1rap antibodies, bispecific antigen binding molecules that bind il1rap and cd3, and uses thereof
04/27/17Pharmaceutical formulations
04/27/17Inhibitors of the interaction between mdm2 and p53
04/06/17Vial holder devices and systems
03/30/17Benzo-fused heterocyclic derivatives useful as agonists of gpr120
03/16/17Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
03/16/17Haptens of aripiprazole
03/16/17Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]benzo-diazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives
03/09/17Therapeutic compounds and synthesis
03/09/17Therapeutic compounds for pain and synthesis thereof
03/09/17Therapeutic compounds for pain and synthesis thereof
03/09/17Therapeutic compounds for pain and synthesis thereof
03/09/17Therapeutic compound for pain and synthesis thereof
03/02/17Process for the preparation of histamine h3 receptor modulators
03/02/17Chemically modified quinoline and quinolone derivatives useful as cb-1 inverse agonists
03/02/17Indazole derivatives useful as cb-1 inverse agonists
03/02/17Benzimidazole derivatives useful as cb-1 inverse agonists
Patent Packs
03/02/17Identification of jc viral epitopes by cytotoxic t lymphocytes in healthy individuals and their use in assays
02/23/17Anti-vista antibodies and fragments
02/23/17Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof
02/16/17Gpr40 agonists for the treatment of type ii diabetes
02/16/17Gpr40 agonists for the treatment of type ii diabetes
02/16/17Gpr40 agonists for the treatment of type ii diabetes
02/16/17Channel for trapping particles to be fed to said channel with a fluid
02/16/17Antibodies to paliperidone and use thereof
02/09/17Antibodies to olanzapine and use thereof
02/02/17Tetrahydro-benzoimidazolyl modulators of tgr5
02/02/17Piperidine/piperazine derivatives
02/02/17Antibodies to aripiprazole and use thereof
01/26/17Macrocylic pyridine derivatives
01/26/17Macrocylic pyrimidine derivatives
01/19/17Substituted 2-azabicycles and their use as orexin receptor modulators
Patent Packs
01/12/17Substituted 4-azaindoles and their use as glun2b receptor modulators
12/29/16P2x7 modulators
12/29/16Substituted 7-azabicycles and their use as orexin receptor modulators
12/29/16Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
12/22/16Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
11/24/16Methods and kits for treating depression
11/24/16Methods for the treatment and prevention of renal disorders and fatty liver disorders
11/24/16Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
11/24/16Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
11/24/16Antibodies to quetiapine and use thereof
11/17/16(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
11/03/16Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/03/16Tetrahydro-pyrimidoazepines as modulators of trpv1
10/27/16Substituted imidazoles as n-type calcium channel blockers
10/20/16Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
10/20/16Whole blood based mrna markers for predicting prostate cancer and methods of detecting the same
10/06/16Ibrutinib combination therapy
10/06/16Fgfr/pd-1 combination therapy for the treatment of cancer
09/29/16Phenyl linked quinolinyl modulators of rorgammat
09/08/16New 1-(4-pyrimidinyl)-1h-pyrrolo[3,2-c]pyridine derivatives as nik inhibitors
08/11/16New 3-(1h-pyrazol-4-yl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors
07/21/16Quinazoline derivatives
07/14/164-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
07/14/16Cinnoline derivatives useful as cb-1 receptor inverse agonists
07/07/16Combinations of pyrimethanil and monoterpenes
07/07/161,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of mglur2 receptors
06/23/16Vial holder devices, methods and systems
06/16/16Benzoimidazoles as prolyl hydroxylase inhibitors
06/16/16Process for the preparation of heterocyclic ester derivatives
06/09/16Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
Social Network Patent Pack
06/02/165,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
05/19/16Heteroaryl linked quinolinyl modulators of roryt
05/12/164-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (bace)
05/12/16Electronic medication adherence, identification, and dispensation
05/05/16Thiazoles as modulators of roryt
05/05/16Inhibitors of c-fms kinase
05/05/16Amide substituted thiazoles as modulators of roryt
05/05/16Trifluoromethyl alcohols as modulators of roryt
04/28/166,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
04/28/164-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (bace)
Patent Packs
04/28/164-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2h)-one derivatives as inhibitors of beta-secretase (bace)
04/21/16Medication dosage indicator
04/21/16Quinazolinedione derivatives as parp inhibitors
04/21/161,2,5-substituted benzimidazoles as flap modulators
04/14/16Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes
04/07/16Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors
03/31/16Use of fgfr mutant gene panels in identifying cancer patients that will be responsive to treatment with an fgfr inhibitor
03/17/16Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression
03/17/16Substituted 2-azabicycles and their use as orexin receptor modulators
03/17/163-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors for the treatment of cancer
03/10/16Quinazoline derivatives useful as cb-1 inverse agonists
03/10/16Cd123 binding agents and uses thereof
02/25/16Substituted 2-azabicycles and their use as orexin receptor modulators
02/25/16Substituted 2-azabicycles and their use as orexin receptor modulators
02/18/16Method for the treatment of depression
02/18/16Serotonin receptor modulators
02/18/16Substituted piperidine compounds and their use as orexin receptor modulators
02/18/161,2,5-substituted benzimidazoles as flap modulators
02/18/16Inhibitors of c-fms kinase
02/18/16Substituted 7-azabicycles and their use as orexin receptor modulators
02/11/161,2,6-substituted benzimidazoles as flap modulators
02/11/16Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]pyridin-5-yl)-4-quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4-quinazolinamine derivatives as perk inhibitors
02/11/16P2x7 modulators
02/11/16P2x7 modulators
01/28/16Combination of canagliflozin and probenecid for the treament of hyperuricemia
01/28/16Physiological ligands for gpr139
01/28/16P2x7 modulators
01/21/164-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide for the treatment of hodgkin's lymphoma
01/21/16Substituted pyridine derivatives useful as c-fms kinase inhibitors
01/21/16P2x7 modulators
Patent Packs
01/14/16Pyrazine gpr40 agonists for the treatment of type ii diabetes
01/14/16Benzamide derivative useful as fasn inhibitors for the treatment of cancer
01/07/16Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancer
01/07/16Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
12/31/15Processes and intermediates for preparing a medicament
12/31/15Flap modulators
12/24/15Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-a]]quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological of metabolic disorders
12/24/15Flap modulators
12/10/15Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
12/10/15Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
12/03/15Formulation for co-therapy treatment of diabetes
12/03/15Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
11/26/15Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
11/19/15Substituted 7-azabicycles and their use as orexin receptor modulators
11/12/15Drug combinations comprising a dgat inhibitor and a ppar-agonist
11/12/15P2x7 modulators
11/12/15Piperidine/piperazine derivatives
11/12/15Sodium channel sensitive conopeptides and analogs, including compositions and methods thereof
11/12/15Biological markers for identifying patients for treatment with abiraterone acetate
10/29/15Combinations of pyrimethanil and monoterpenes
Social Network Patent Pack
10/29/15Novel tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
10/15/15[1,2,4]triazolo[4,3-a]pyrazines as p2x7 modulators
10/08/15Benzoimidazoles as prolyl hydroxylase inhibitors
09/17/15Flap modulators
09/10/15Flap modulators
09/03/151,2,5-substituted benzimidazoles as flap modulators
08/27/15Quinoline derivatives useful as cb-1 inverse agonists
08/27/15Quinoline derivatives useful as cb-1 inverse agonists
08/20/15Process for the preparation of c-fms kinase inhibitors
07/23/15Inhibitors of phosphodiesterase 10 enzyme
07/16/154-aminoquinazolinyl compounds as prolyl hydroxylase inhibitors
06/25/15Substituted 2-azabicycles and their use as orexin receptor modulators
06/18/15Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancer
06/11/15Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
06/04/15Benzimidazole derivatives useful trpm8 channel modulators
05/28/15Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
05/21/15Process for preparing 2-[(2e)-2-fluoro-2-(3-piperidinylidene)ethyl]-1h-isoindole-1,3(2h)-dione
04/30/151,2,6-substituted benzimidazoles as flap modulators
04/23/15Quinolinyl modulators of roryt
04/16/15Heteroaryl linked quinolinyl modulators of rorgammat
Social Network Patent Pack
04/16/15Methylene linked quinolinyl modulators of roryt
04/16/15Alkyl linked quinolinyl modulators of roryt
04/16/15Secondary alcohol quinolinyl modulators of roryt
04/16/15Phenyl linked quinolinyl modulators of roryt
04/09/15Modulators of fatty acid amide hydrolase
04/09/15Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancer
04/02/15Method of inhibiting c-kit kinase
03/26/15Polymeric microemulsions
03/26/15Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
03/26/15Use of tralopyril against marine woodborers
03/19/15Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
03/19/15Fused cyclopentyl antagonists of ccr2
03/12/15Phthalazine derivatives as parp inhibitors
03/05/15Antibacterial quinoline derivatives
02/19/15Inhibitors of c-fms kinase
02/19/15Substituted imidazoles as n-type calcium channel blockers
02/19/15Antibacterial quinoline derivatives
02/05/15Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
01/29/15Method to prevent deactivation of metal catalysts in catalytic polymerisation processes
01/01/15Pharmaceutical formulations
12/25/14Inhibitors of c-fms kinase
12/18/14Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
12/11/145-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
12/11/14Pde 10a inhibitors for the treatment of type ii diabetes
12/11/14Pde 10a inhibitors for the treatment of type ii diabetes
11/20/14Process for the preparation of histamine h3 receptor modulators
11/13/14Indazole compounds useful as ketohexokinase inhibitors
11/13/14Physiological ligands for gpr139
09/18/14Pharmaceutical composition of s-ketamine hydrochloride
09/18/14P2x7 modulators
Social Network Patent Pack
09/18/14P2x7 modulators
09/18/14Substituted piperidine compounds and their use as orexin receptor modulators
09/18/14P2x7 modulators
09/18/14Substituted 2-azabicycles and their use as orexin receptor modulators
09/18/14P2x7 modulators
09/18/14Benzo-fused heterocyclic derivatives useful as agonists of gpr120
09/18/14Gpr120 agonists for the treatment of type ii diabetes
09/18/14Bicyclic pyrrole derivatives useful as agonists of gpr120
09/18/14Pharmaceutical composition of s-ketamine hydrochloride
09/18/14Pharmaceutical composition of s-ketamine hydrochloride
09/18/14Pharmaceutical composition of s-ketamine hydrochloride
09/18/14Process for the preparation of (2,3-dihydro-benzo[b][1,4]dioxin-2-yl) methanol derivatives
09/11/14Dual sglt1/sglt2 inhibitors
09/11/14Macrocyclic quinazole derivatives and their use as mtki
09/11/14Benzoimidazoles as prolyl hydroxylase inhibitors
09/11/14Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
09/11/143-cyano-quinoline derivatives with antiproliferative activity
09/04/14Novel indole derivatives as selective androgen receptor modulators (sarms)
08/28/14Azetidinyl diamides as monoacylglycerol lipase inhibitors
08/28/14Inhibitors of c-fms kinase
08/28/14Sulfamides as trpm8 modulators
08/07/14Flap modulators
08/07/14Flap modulators
08/07/14Heteroaryl substituted urea modulators of fatty acid amide hydrolase
08/07/14Haptens of quetiapine
07/31/14Haptens of olanzipine
07/31/14Haptens of paliperidone
07/24/14Process for the preparation of compounds useful as inhibitors of sglt-2
07/24/14Process for the preparation of compounds useful as inhibitors of sglt-2







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Janssen Pharmaceutica Nv in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Janssen Pharmaceutica Nv with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';